Association of variants of the -116 site of the butyrylcholinesterase BCHE gene to enzyme activity and body mass index

Chemico-Biological Interactions

Volumn 175, Issue 1-3, 2008, Pages 115-118

  Furtado Alle, Lupe ^a   Andrade, Fabiana A ^a   Nunes, Kelly ^a   Mikami, Liya R ^a   Souza, Ricardo L R ^a   Chautard Freire Maia, Eleidi A ^a  

^a FEDERAL UNIVERSITY OF PARANÁ   (Brazil)

Author keywords

116A mutation; BCHE gene variants; Body mass index; Butyrylcholinesterase activity; K mutation

Indexed keywords

ADENINE; CHOLINESTERASE; GUANINE; THYMINE;

5' UNTRANSLATED REGION; ARTICLE; BCHE GENE; BLOOD DONOR; BODY MASS; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME CONFORMATION; EXON; GENE; GENE FUNCTION; GENETIC VARIABILITY; GENOTYPE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; OBESITY; TRANSCRIPTION REGULATION; TRANSLATION REGULATION;

BASE SEQUENCE; BODY MASS INDEX; BUTYRYLCHOLINESTERASE; CASE-CONTROL STUDIES; DNA PRIMERS; HUMANS; LINKAGE DISEQUILIBRIUM; MUTATION; OBESITY;

EID: 50649083923     PISSN: 00092797     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cbi.2008.04.019     Document Type: Article

References (22)

1. k, another quantitative variant at cholinesterase locus 1. J. Med. Genet. 15 (1978) 27-29
2. Bartels C.F., van der Spek A.F.L., and La Du B.N. Two polymorphisms in the non-coding regions of the BCHE gene. Nucleic Acids Res. 18 (1990) 6171
3. Souza R.L.R., Castro R.M.V., Pereira L., Freund A.A., Culpi L., and Chautard-Freire-Maia E.A. Frequencies of the butyrylcholinesterase K mutation in the Brazilian population of European and African origin. Hum. Biol. 70 (1998) 965-970
4. Lehmann D.J., Johnston C., and Smith A.D. Synergy between the genes for butyrylcholinesterase K variant and apolipoprotein E4 in late-onset confirmed Alzheimer's disease. Hum. Mol. Genet. 6 (1997) 1933-1936
5. Lehmann D.J., Nagy Z., Litchfield S., Borja M.C., and Smith A.D. Association of butyrylcholinesterase K variant with cholinesterase-positive neuritic plaques in the temporal cortex in late-onset Alzheimer's disease. Hum. Genet. 106 (2000) 447-452
6. Holmes C., Ballard C., Lehmann D., Smith A.D., Beaumont H., Day I.N., Khan M.N., Lovestone S., McCulley M., Morris C.M., Munoz D.G., O'Brien K., Russ C., Del Ser T., and Warden D. Rate of progression of cognitive decline in Alzheimer's disease: effect of butyrylcholinesterase K gene variation. J. Neurol. Neurosurg. Psychiatry 76 (2005) 640-643
7. Souza R.L.R., Fadel-Picheth C., Allebrandt K.V., Furtado L., and Chautard-Freire-Maia E.A. Possible influence of the BCHE locus of butyrylcholinesterase on height and body mass index. Am. J. Phys. Anthropol. 126 (2005) 329-334
8. Arpagaus M., Kott M., Vatsis K.P., Bartels C.F., La Du B.N., and Lockridge O. Structure of the gene for human butyrylcholinesterase. Evidence for a single copy. Biochemistry 29 (1990) 124-131
9. Lahiri D.K., and Nurnberger Jr. J.I. A rapid non-enzymatic method for the preparation of HMW DNA from blood for RFLP studies. Nucleic Acids Res. 19 (1991) 5444
10. Höhler T., Hundt M., Rittner C., Schneider P.M., and Büschenfelde K.H.M. Cholinesterase variants: rapid characterization by PCR/SSCP and evidence for molecular homogeneity. J. Med. Genet. 32 (1995) 109-112
11. Budowle B., Chakraborty R., Giusti A.M., Eisenberg A.J., and Allen R.E. Analysis of the VNTR locus D1S80 by the PCR followed by high-resolution PAGE. Am. J. Hum. Genet. 48 (1991) 137-144
12. Dietz A.A., Rubinstein H.M., Lubrano T., and Hodges L.K. Improved method for the differentiation of cholinesterase variants. Am. J. Hum. Genet. 24 (1972) 58-64
13. S. Schneider, D. Roessli, L. Excoffier, A Software for Population Genetics Data Analysis, Version 2000, Genetics and Biometry Laboratory, University of Geneva, Switzerland, 2000, http://anthropologie.unige.ch/arlequin/.
14. Bartels C.F., Jensen F.S., Lockridge O., van der Spek A.F.L., Rubinstein H.M., Lubrano T., and La Du B.N. DNA mutation associated with the human butyrylcholinesterase K-variant and its linkage to the atypical variant mutation and other polymorphic sites. Am. J. Hum. Genet. 50 (1992) 1086-1103
15. Altamirano C.V., Bartels C.F., and Lockridge O. The butyrylcholinesterase K-variant shows similar cellular protein turnover and quaternary interaction to the wild type enzyme. J. Neurochem. 74 (2000) 869-877
16. Kojima M., Hosoda H., Matsuo H., and Kangawa K. Ghrelin: discovery of the natural endogenous ligand for the growth hormone secretagogue receptor. Trends Endocrinol. Metab. 12 (2001) 118-126
17. De Vriese C., Gregoire F., Lema-Kisoka R., Waelbroeck M., Robberecht P., and Delporte C. Ghrelin degradation by serum and tissue homogenates: identification of the cleavage sites. Endocrinology 145 (2004) 4997-5005
18. Tschöp M., Weyer C., Tataranni P.A., Devanarayan V., Ravussin E., and Heiman M.L. Circulating ghrelin levels are decreased in human obesity. Diabetes 50 (2001) 707-709
19. Lockridge O., Duysen E.G., and Li B. Functions of butyrylcholinesterase in the butyrylcholinesterase knockout mouse. The IXth International Meeting on Cholinesterases, S-II-2 (2007) 27
20. Stewart D.J., Inaba T., Tang B.K., and Kalow W. Hydrolysis of cocaine in human-plasma by cholinesterase. Life Sci. 20 (1977) 1557-1564
21. Doctor B.P., Raveh L., Wolfe A.D., Maxwell D.M., and Ashani Y. Enzymes as pretreatment drugs for organophosphate toxicity. Neurosci. Biobehav. Rev. 15 (1991) 123-128
22. Broomfield C.A., Maxwell D.M., Solana R.P., Castro C.A., Finger A.V., and Lenz D.E. Protection by butyrylcholinesterase against organophosphorus poisoning in nonhuman primates. J. Pharmacol. Exp. Ther. 259 (1991) 633-638